Literature DB >> 12603788

Spectral analysis of all-night human sleep EEG in narcoleptic patients and normal subjects.

Junko Mukai1, Sunao Uchida, Shinichi Miyazaki, Kyoko Nishihara, Yutaka Honda.   

Abstract

To investigate the pathophysiology of narcoleptic patients' sleep in detail, we analysed and compared the whole-night polysomnograms of narcoleptic patients and normal human subjects. Eight drug-naive narcoleptic patients and eight age-matched normal volunteers underwent polysomnography (PSG) on two consecutive nights. In addition to conventional visual scoring of the polysomnograms, rapid eye movement (REM)-density and electroencephalograph (EEG) power spectra analyses were also performed. Sleep onset REM periods and fragmented nocturnal sleep were observed as expected in our narcoleptic patients. In the narcoleptic patients, REM period duration across the night did not show the significant increasing trend that is usually observed in normal subjects. In all narcoleptic patient REM periods, eye movement densities were significantly increased. The power spectra of narcoleptic REM sleep significantly increased between 0.3 and 0.9 Hz and decreased between 1.0 and 5.4 Hz. Further analysis revealed that non-rapid eye movement (NREM) period duration and the declining trend of delta power density in the narcoleptic patients were not significantly different from the normal subjects. Compared with normal subjects, the power spectra of narcoleptic NREM sleep increased in the 1.0-1.4 Hz and 11.0-11.9 Hz frequency bands, and decreased in a 24.0-26.9 Hz frequency band. Thus, increased EEG delta and decreased beta power densities were commonly observed in both the NREM and REM sleep of the narcoleptic patients, although the decrease in beta power during REM sleep was not statistically significant. Our visual analysis revealed fragmented nocturnal sleep and increased phasic REM components in the narcoleptic patients, which suggest the disturbance of sleep maintenance mechanism(s) and excessive effects of the mechanism(s) underlying eye movement activities during REM sleep in narcolepsy. Spectral analysis revealed significant increases in delta components and decreases in beta components, which suggest decreased activity in central arousal mechanisms. These characteristics lead us to hypothesize that two countervailing mechanisms underlie narcoleptic sleep pathology.

Entities:  

Mesh:

Year:  2003        PMID: 12603788     DOI: 10.1046/j.1365-2869.2003.00331.x

Source DB:  PubMed          Journal:  J Sleep Res        ISSN: 0962-1105            Impact factor:   3.981


  16 in total

Review 1.  Disrupted nighttime sleep in narcolepsy.

Authors:  Thomas Roth; Yves Dauvilliers; Emmanuel Mignot; Jacques Montplaisir; Josh Paul; Todd Swick; Phyllis Zee
Journal:  J Clin Sleep Med       Date:  2013-09-15       Impact factor: 4.062

2.  DQB1*0602 predicts interindividual differences in physiologic sleep, sleepiness, and fatigue.

Authors:  Namni Goel; Siobhan Banks; Emmanuel Mignot; David F Dinges
Journal:  Neurology       Date:  2010-10-26       Impact factor: 9.910

3.  Sleep-stage transitions during polysomnographic recordings as diagnostic features of type 1 narcolepsy.

Authors:  Julie Anja Engelhard Christensen; Oscar Carrillo; Eileen B Leary; Paul E Peppard; Terry Young; Helge Bjarrup Dissing Sorensen; Poul Jennum; Emmanuel Mignot
Journal:  Sleep Med       Date:  2015-07-07       Impact factor: 3.492

Review 4.  Has adult sleep duration declined over the last 50+ years?

Authors:  Shawn D Youngstedt; Eric E Goff; Alexandria M Reynolds; Daniel F Kripke; Michael R Irwin; Richard R Bootzin; Nidha Khan; Girardin Jean-Louis
Journal:  Sleep Med Rev       Date:  2015-08-28       Impact factor: 11.609

5.  A variant at 9q34.11 is associated with HLA-DQB1*06:02 negative essential hypersomnia.

Authors:  Taku Miyagawa; Seik-Soon Khor; Hiromi Toyoda; Takashi Kanbayashi; Aya Imanishi; Yohei Sagawa; Nozomu Kotorii; Tatayu Kotorii; Yu Ariyoshi; Yuji Hashizume; Kimihiro Ogi; Hiroshi Hiejima; Yuichi Kamei; Akiko Hida; Masayuki Miyamoto; Azusa Ikegami; Yamato Wada; Masanori Takami; Yuichi Higashiyama; Ryoko Miyake; Hideaki Kondo; Yota Fujimura; Yoshiyuki Tamura; Yukari Taniyama; Naoto Omata; Yuji Tanaka; Shunpei Moriya; Hirokazu Furuya; Mitsuhiro Kato; Yoshiya Kawamura; Takeshi Otowa; Akinori Miyashita; Hiroto Kojima; Hiroh Saji; Mihoko Shimada; Maria Yamasaki; Takumi Kobayashi; Rumi Misawa; Yosuke Shigematsu; Ryozo Kuwano; Tsukasa Sasaki; Jun Ishigooka; Yuji Wada; Kazuhito Tsuruta; Shigeru Chiba; Fumiaki Tanaka; Naoto Yamada; Masako Okawa; Kenji Kuroda; Kazuhiko Kume; Koichi Hirata; Naohisa Uchimura; Tetsuo Shimizu; Yuichi Inoue; Yutaka Honda; Kazuo Mishima; Makoto Honda; Katsushi Tokunaga
Journal:  J Hum Genet       Date:  2018-09-28       Impact factor: 3.172

6.  Drug-related Sleep Stage Changes: Functional Significance and Clinical Relevance.

Authors:  Timothy Roehrs; Thomas Roth
Journal:  Sleep Med Clin       Date:  2010-12-01

7.  REM Sleep Theta Changes in Frequent Nightmare Recallers.

Authors:  Louis-Philippe Marquis; Tyna Paquette; Cloé Blanchette-Carrière; Gaëlle Dumel; Tore Nielsen
Journal:  Sleep       Date:  2017-09-01       Impact factor: 5.849

8.  Behavioral state instability in orexin knock-out mice.

Authors:  Takatoshi Mochizuki; Amanda Crocker; Sarah McCormack; Masashi Yanagisawa; Takeshi Sakurai; Thomas E Scammell
Journal:  J Neurosci       Date:  2004-07-14       Impact factor: 6.167

9.  The diagnostic value of power spectra analysis of the sleep electroencephalography in narcoleptic patients.

Authors:  Julie Anja Engelhard Christensen; Emil Gammelmark Schreiner Munk; Paul E Peppard; Terry Young; Emmanuel Mignot; Helge Bjarrup Dissing Sorensen; Poul Jennum
Journal:  Sleep Med       Date:  2015-09-15       Impact factor: 3.492

10.  Challenging sleep homeostasis in narcolepsy-cataplexy: implications for non-REM and REM sleep regulation.

Authors:  Ramin Khatami; Hans-Peter Landolt; Peter Achermann; Martin Adam; Julia V Rétey; Esther Werth; Dagmar Schmid; Claudio L Bassetti
Journal:  Sleep       Date:  2008-06       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.